Paul M. Ridker is Director of the Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital and the Eugene Braunwald Professor of Medicine at Harvard School of Medicine (HMS). His clinical interests include coronary artery disease and the underlying causes and prevention of atherosclerotic disease. His research focuses on inflammatory mediators of heart disease and the molecular and genetic epidemiology of haemostasis and thrombosis, with particular interests in biomarkers for coronary disease, “predictive” medicine, and the underlying causes and prevention of atherosclerotic disease.

Contributions

Controversy: Are we ready to treat inflammation for ASCVD prevention?92nd EAS Congress 2024Controversy: Are we ready to treat inflammation for ASCVD prevention?Should we target inflammation?90th EAS Congress 2022Plenary 3: From lifestyle to designer therapies(AtherothrombosisInflammationPhysiopath)Inflammation, Inhibition and Atherothrombosis87th EAS Congress 2019